![Rachel McMinn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 43 M $ al 31/07/2026
Rachel L.
McMinn is the founder of Neurogene OpCo., founded in 2018, serving as Chief Executive Officer since 2019.
Dr. McMinn is the founder of Neurogene, Inc., founded in 2018, serving as Executive Chairman & Chief Executive Officer since 2023.
Dr. McMinn is currently Director at EveryONE Medicines, Inc. since 2021.
Former positions include Director at Cowen & Co. LLC.
from 2007 to 2009, Senior Analyst at Piper Sandler & Co. (Broker), Chief Business & Strategy Officer at Intercept Pharmaceuticals, Inc. from 2014 to 2017, Principal at Banc of America Securities LLC in 2009, Analyst at Piper Sandler & Co., and Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Education includes a doctorate from The Scripps Research Institute and an undergraduate degree from Cornell University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
8,36 % | 07/04/2026 | 1.302.474 ( 8,36 % ) | 43 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Director Ejecutivo | 01/01/2018 |
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Director/Miembro de la Junta | 01/01/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2017 |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 30/04/2009 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/03/2009 |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/12/2006 |
Piper Sandler & Co.
 Piper Sandler & Co. Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Piper Sandler & Co.
Piper Sandler & Co. Investment ManagersFinance Provides investment advice | Finance |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Health Technology |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
